Business
Rafarma Pharmaceuticals, Inc. (RAFA) Enters New Distribution Agreement with Amber Pharma Distribution Group
Rafarma Pharmaceuticals, Inc. (RAFA) Enters New Distribution Agreement with Amber Pharma Distribution Group.
About this update from Rafarma Pharmaceuticals, Inc. (wy)
[{"type":"text","content":"\n\n\n\n\n\n\n\nRafarma Pharmaceuticals, Inc. (RAFA) Enters New Distribution Agreement with Amber Pharma Distribution Group\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nRafarma Pharmaceuticals, Inc. (RAFA) Enters New Distribution Agreement with Amber Pharma Distribution Group\n\nPR Newswire\n\nTERBUNY, Russia, Sept. 10, 2013\n\n\n\n\n\n\nTERBUNY, Russia, Sept. 10, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc., OTC symbol \"RAFA,\" announced it has entered into a new multi-year distribution contract with Amber Pharma Distribution Group, a boutique international business development firm. The principals of Amber Pharma have more than 75 years of combined international business development experience in a wide range of industry sectors including pharmaceuticals, finance, software, telecommunications and trade. It is intended that this new alliance with Rafarma will lead to over $100 million USD in new sales within the next 24 to 36 months. \n\n\nCEO Dave Anderson stated: \"We are delighted to form this strategic alliance with Amber Pharma. This is just the beginning of Rafarma's aggressive expansion into producing high-quality pharmaceutical products with partners all over the globe. If any distributor, supplier or retail provider is looking for state-of-the-art pharma production at competitive pricing, the Terbuny plant is the place, and its production capacity is still expanding.\"\n\n\n\nAbout Rafarma Pharmaceuticals, Inc. \n\n\n\nOperating from a new 270,000 square-foot state-of-the-art manufacturing and distribution facility in Russia, Rafarma Pharmaceuticals produces generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products that are approved by the Ministry of Health of Russian Federation. For the last three years, the Russian Government has been highly focused on bolstering the development of the nation's domestic pharmaceutical industry. Rafarma Pharmaceuticals' mission is to work with the auspices of aggressive federal initiatives to fast-track the modernization of Russia's pharmaceutical...